<DOC>
	<DOC>NCT00444652</DOC>
	<brief_summary>This trial is an assessment of the efficacy of three thromboprophylaxis regimens in two types of bariatric surgery. - gastric banding and gastric bypass on anti-Xa activity levels The study includes two groups of 150 patients scheduled for gastric banding or gastric bypass. Assessment of anti-Xa levels before and 4 hours after the injections from day 0 to 2 in order to determine the best prophylactic regimen allowing expected values ranged between 0.3 and 0.5 IU / ml.</brief_summary>
	<brief_title>Thromboprophylaxis and Bariatric Surgery</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<criteria>BMI over 40 Gastric banding or gastric bypass Renal insufficiency Thrombopenia Long term anticoagulant treatment Pregnancy Allergy to heparin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Thromboprophylaxis</keyword>
	<keyword>Bariatric surgery</keyword>
	<keyword>prevention of venous thromboembolism in bariatric surgery</keyword>
</DOC>